-
Perspective From Patients as Partners: Sustaining Patient Engagement Through Organizational Changes
At Patients as Partners 2026, CEO Cheryl Lubbert shared how sustaining patient engagement through organizational change requires intentional design, with systems built to hold as teams, priorities, and programs shift.
-
Pharma USA 2026: AI Scales Reach in Pharma. But What Actually Changes Patient and HCP Behavior?
AI is becoming a baseline expectation in pharma. At Pharma USA 2026, discussions reflected less focus on whether AI should be used and more on how it is being applied…
-
Approval Is Not the Finish Line: Turning Late-Stage Clinical Evidence Into Real-World Impact
Late-stage clinical programs establish the evidence required for regulatory evaluation, but they do not guarantee adoption, access, or commercial performance. Translating that evidence into real-world impact requires patient-centered execution and…
-
How Peer Mentors Help Patients Start and Stay on Therapy in Rare Disease
In rare disease, a missing piece in starting and staying on therapy is often lived perspective. Patients and their care partners may begin rare disease treatment with no peer reference…
-
Turning Data into Dialogue: How Numbers Build Trust Between Patients and Clinicians
By Cheryl Lubbert, CEO of Reverba Global In healthcare, every word matters – but the way we communicate those words, and the numbers behind them, is changing. For patients to…
